Business Description
KoBioLabs Inc
ISIN : KR7348150004
Share Class Description:
XKRX:348150: Ordinary SharesCompare
Compare
Traded in other countries / regions
348150.Korea IPO Date
2020-11-18Description
KoBioLabs Inc is a biotechnology company focused on Microbiome therapeutics. It is involved in the research of medicines for Immune, Metabolic and Neurological Diseases.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.49 | |||||
| Equity-to-Asset | 0.39 | |||||
| Debt-to-Equity | 0.4 | |||||
| Debt-to-EBITDA | -3.03 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.05 | |||||
| Beneish M-Score | -1.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 61.1 | |||||
| 3-Year EBITDA Growth Rate | 50.1 | |||||
| 3-Year EPS without NRI Growth Rate | 11.1 | |||||
| 3-Year FCF Growth Rate | -9.3 | |||||
| 3-Year Book Growth Rate | -12.8 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.74 | |||||
| 9-Day RSI | 39.22 | |||||
| 14-Day RSI | 40.04 | |||||
| 6-1 Month Momentum % | -10.51 | |||||
| 12-1 Month Momentum % | -27.63 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.59 | |||||
| Quick Ratio | 4.32 | |||||
| Cash Ratio | 3.86 | |||||
| Days Inventory | 41.61 | |||||
| Days Sales Outstanding | 16.54 | |||||
| Days Payable | 0.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.7 | |||||
| Shareholder Yield % | -4.41 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 67.24 | |||||
| Operating Margin % | -18.43 | |||||
| Net Margin % | -15.4 | |||||
| FCF Margin % | -18.25 | |||||
| ROE % | -19.79 | |||||
| ROA % | -8.4 | |||||
| ROIC % | -22.2 | |||||
| ROC (Joel Greenblatt) % | -22.35 | |||||
| ROCE % | -8.32 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.57 | |||||
| PB Ratio | 2.44 | |||||
| Price-to-Tangible-Book | 2.47 | |||||
| EV-to-EBIT | -9.84 | |||||
| EV-to-EBITDA | -13.98 | |||||
| EV-to-Revenue | 1.24 | |||||
| EV-to-FCF | -5.43 | |||||
| Price-to-Net-Current-Asset-Value | 20.05 | |||||
| Earnings Yield (Greenblatt) % | -10.16 | |||||
| FCF Yield % | -11.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
KoBioLabs Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 61,320.364 | ||
| EPS (TTM) (â‚©) | -502 | ||
| Beta | 1.13 | ||
| Volatility % | 36.29 | ||
| 14-Day RSI | 40.04 | ||
| 14-Day ATR (â‚©) | 291.43186 | ||
| 20-Day SMA (â‚©) | 5398.75 | ||
| 12-1 Month Momentum % | -27.63 | ||
| 52-Week Range (â‚©) | 4730 - 14150 | ||
| Shares Outstanding (Mil) | 19.37 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
KoBioLabs Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
KoBioLabs Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
KoBioLabs Inc Frequently Asked Questions
What is KoBioLabs Inc(XKRX:348150)'s stock price today?
The current price of XKRX:348150 is â‚©5140.00. The 52 week high of XKRX:348150 is â‚©14150.00 and 52 week low is â‚©4730.00.
When is next earnings date of KoBioLabs Inc(XKRX:348150)?
The next earnings date of KoBioLabs Inc(XKRX:348150) is .
Does KoBioLabs Inc(XKRX:348150) pay dividends? If so, how much?
KoBioLabs Inc(XKRX:348150) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers